Hydroxyurea is a medicine that helps a lot of people who have sickle cell disease, It keeps blood cells round and flexible, so they flow better and deliver oxygen to the body more easily. This means less pain and fewer trips to the hospital.

Hydroxyurea is a medication that has been shown to be effective in the management of sickle cell disease. It works by stimulating the production of fetal hemoglobin, which is a type of hemoglobin that is not affected by the genetic mutation that causes sickle cell disease. By promoting the production of fetal hemoglobin, hydroxyurea can reduce the number of sickle cells in circulation and lower the risk of complications such as pain crises, acute chest syndrome, and stroke.

Studies have shown that hydroxyurea can significantly reduce the frequency of vaso-occlusive crises (pain episodes) in patients with sickle cell disease, and also improve overall survival. It is currently the only FDA-approved drug for reducing the frequency of painful crises and the need for blood transfusions in patients with sickle cell anemia.

Hydroxyurea is generally safe and well-tolerated, but it can have side effects such as an increased risk of infections and mild bone marrow suppression. Patients who take hydroxyurea must be carefully monitored by their healthcare provider to ensure that they do not experience any serious side effects.

Overall, hydroxyurea has been an important therapeutic advance in the management of sickle cell disease and is an important treatment option for many patients. However, it is not a cure for the disease, and researchers are continuing to explore new treatment options, including gene therapy.